1-3 of 3
Deborah A. Fuchs
Close
Sort by
Journal Articles

HLA-DR Protein Status Predicts Survival in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with the MACOP-B Chemotherapy Regimen.

Lisa M. Rimsza, MD, Pedro Farinha, MD, Deborah A. Fuchs, MD, Hamid Masoudi, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD
Journal: Blood
Blood (2004) 104 (11): 3273.
https://doi.org/10.1182/blood.V104.11.3273.3273
Published: 2004
Journal Articles

Gene Expression Profiling, Frozen and Paraffin Section Immunohistochemistry, and In Situ Hybridization for Determination of Monoclonality in Diffuse Large B-Cell Lymphoma.

Matthew W. Andres, DO, Robin A. Roberts, BS, Debbie J. Mustacich, PhD, Randy D. Gascoyne, MD, Deborah A. Fuchs, MD, Michael X. Wang, MD, Rita M. Braziel, MD, Wing C. Chan, MD, Thomas M. Grogan, MD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2004) 104 (11): 4553.
https://doi.org/10.1182/blood.V104.11.4553.4553
Published: 2004
Journal Articles

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Clinical Trials & Observations
Lisa M. Rimsza, Robin A. Roberts, Thomas P. Miller, Joseph M. Unger, Michael LeBlanc, Rita M. Braziel, Dennis D. Weisenberger, Wing C. Chan, H. Konrad Muller-Hermelink, Elaine S. Jaffe, Randy D. Gascoyne, Elias Campo, Deborah A. Fuchs, Catherine M. Spier, Richard I. Fisher, Jan Delabie, Andreas Rosenwald, Louis M. Staudt, Thomas M. Grogan
Journal: Blood
Blood (2004) 103 (11): 4251–4258.
https://doi.org/10.1182/blood-2003-07-2365
Published: 2004